Volitionrx (VNRX) Capital Expenditures (QoQ) (2011 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Volitionrx | 101.83 Mn | 99.36 Mn | -1.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 4,146.85% |
| Mar 31, 2025 | -97.51% |
| Dec 31, 2024 | -46.90% |
| Sep 30, 2024 | 652.92% |
| Jun 30, 2024 | -63.68% |
| Mar 31, 2024 | 106.45% |
| Dec 31, 2023 | -200.00% |
| Dec 31, 2022 | 77.81% |
| Sep 30, 2022 | -39.87% |
| Jun 30, 2022 | 334.26% |
| Mar 31, 2022 | -3.05% |
| Dec 31, 2021 | -9.33% |
| Sep 30, 2021 | -35.32% |
| Jun 30, 2021 | -54.70% |
| Mar 31, 2021 | -61.63% |
| Dec 31, 2020 | 1,430.38% |
| Sep 30, 2020 | -91.12% |
| Jun 30, 2020 | 380.64% |
| Mar 31, 2020 | -117.90% |
| Dec 31, 2019 | -23.72% |
| Sep 30, 2019 | 1.65% |
| Jun 30, 2019 | -11.26% |
| Mar 31, 2019 | 5.21% |
| Dec 31, 2018 | -103.81% |
| Sep 30, 2018 | 68.83% |
| Jun 30, 2018 | -406.92% |
| Mar 31, 2018 | -28.63% |
| Dec 31, 2017 | -19.32% |
| Sep 30, 2017 | -70.74% |
| Jun 30, 2017 | -58.85% |
| Mar 31, 2017 | 168.65% |
| Dec 31, 2016 | 1,447.00% |
| Dec 31, 2015 | 64.99% |
| Sep 30, 2015 | -87.16% |
| Jun 30, 2015 | 140.11% |
| Mar 31, 2015 | 240.06% |
| Dec 31, 2014 | -97.86% |
| Sep 30, 2014 | 777.28% |
| Jun 30, 2014 | 58.32% |
| Mar 31, 2014 | 1,806,600.00% |
| Dec 31, 2013 | 200.00% |
| Mar 31, 2013 | -96.26% |
| Dec 31, 2012 | 4,099.78% |
| Sep 30, 2012 | -98.63% |
| Jun 30, 2012 | -11.83% |
| Mar 31, 2012 | -36.36% |
| Dec 31, 2011 | 393.10% |
| Sep 30, 2011 | -375.32% |